Icagen Re-launched Through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D

By: via Benzinga
XRpro Sciences, Inc. today announced its acquisition of assets related to the ion channel biology platform from Pfizer Inc. (NYSE: PFE) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.